At COTA, we are dedicated to fostering a supportive and dynamic work environment.
We believe in empowering our employees to make a difference in the lives of patients and their families. Join us and be part of a team that is revolutionizing healthcare.
Medical oncologist and real-world data leader succeeds Miruna Sasu, whose leadership expanded COTA’s impact across life sciences. A Leader Rooted in Both Medicine and Data COTA, an oncology real-world data and analytics company, today announced that C.K. Wang, MD has been appointed Chief Executive Officer, effective immediately. Dr. Wang has served as COTA’s
3 key takeaways from ASCO 2025: Staying nimble in a changing environment The annual meeting of the American Society of Clinical Oncology (ASCO) is a chance for oncology professionals, patient advocates, data experts, and industry representatives to come together and share the latest research in cancer care. This year, thousands of attendees descended on Chicago […]
…
Since the turn of the century, there’s been a growing recognition that the health of our friends, families, & communities is intimately tied to the health of our physical environment. Safe water, clean air, & a diverse, balanced ecosystem are essential conditions for life to thrive & innovation to flourish.As a company focused on healthcare […]
…
Using AI to transform life sciences data analysis: An early look at CAILIN’s performance COTA has launched the COTA AI Language Insights Network (CAILIN) to expedite data analytics. CAILIN is an oncology trained, on-demand insight generator designed to answer a variety of fundamental questions pertaining to data analytics, including specific cohort size, subgroup breakdowns, […]
…
NEW YORK–(BUSINESS WIRE)–COTA Inc., a leader in real-world data (RWD) and analytics for oncology, announces a new partnership with leading precision oncology company Guardant Health Inc. (Nasdaq: GH) that will allow biopharmaceutical researchers to access the combined resources of COTA’s research-grade electronic health record (EHR) data from academic and community care centers and Guardant’s clinicogenomic […]
…
Findings to be Presented at the San Antonio Breast Cancer Symposium NEW YORK, Dec. 9, 2024 /PRNewswire/ — COTA Inc., a leader in real-world data (RWD) and analytics for oncology, PreciseDx, an innovator in AI-powered digital pathology focused on oncology diagnostics, and Baptist Health South Florida today announced new study results validating the artificial intelligence […]
…
